News + Filings Transactions
|
EASTHAM KARIN
| Date | Name | Symbol | Type | Security | Shares | Price | Value | Ownership | Reported |
| 05/17/2023 | Personalis, Inc. | PSNL | Grant | Stock Option (right to buy) | 40k | $2.07 | $82.8k | | 05/17/2023 |
| 03/16/2023 | VERACYTE, INC. | VCYT | Sale | Common Stock | 18.8k | $22.78 | $427k | | 03/16/2023 |
| 03/16/2023 | VERACYTE, INC. | VCYT | Exercise | Stock Option (right to buy) | 18.8k | $12.12 | $227.2k | | 03/16/2023 |
| 02/28/2023 | VERACYTE, INC. | VCYT | Exercise | Stock Option (right to buy) | 10k | $12.12 | $121.2k | | 02/28/2023 |
| 02/28/2023 | VERACYTE, INC. | VCYT | Sale | Common Stock | 10k | $25.00 | $250k | | 02/28/2023 |
| 09/16/2022 | NEKTAR THERAPEUTICS | NKTR | Grant | | 10.2k | $0.00 | $0 | | 09/16/2022 |
| 09/16/2022 | NEKTAR THERAPEUTICS | NKTR | Grant | Stock Option | 20.4k | $3.47 | $70.8k | | 09/16/2022 |
| 09/13/2022 | NEKTAR THERAPEUTICS | NKTR | Sale | | 21.3k | $3.61 | $76.8k | | 09/13/2022 |
| 06/16/2022 | VERACYTE, INC. | VCYT | Grant | Common Stock | 14.7k | $0.00 | $0 | | 06/16/2022 |
| 05/17/2022 | Personalis, Inc. | PSNL | Grant | Common Stock | 10.8k | $0.00 | $0 | | 05/17/2022 |
| 05/17/2022 | Personalis, Inc. | PSNL | Grant | Stock Option (right to buy) | 15k | $4.81 | $72.3k | | 05/17/2022 |
| 05/10/2022 | GERON CORP | GERN | Grant | Stock Option (right to buy) | 125k | $1.48 | $185k | | 05/10/2022 |
| 04/20/2022 | GERON CORP | GERN | Exercise | Stock Option (right to buy) | 35k | $1.41 | $49.4k | | 04/20/2022 |
| 12/17/2021 | VERACYTE, INC. | VCYT | Sale | Common Stock | 5k | $45.00 | $225k | | 12/17/2021 |
| 12/17/2021 | VERACYTE, INC. | VCYT | Exercise | Stock Option (right to buy) | 5k | $12.12 | $60.6k | | 12/17/2021 |
| 11/01/2021 | VERACYTE, INC. | VCYT | Sale | Common Stock | 200 | $47.73 | $9.5k | By IRA | 11/01/2021 |
| 11/01/2021 | VERACYTE, INC. | VCYT | Sale | Common Stock | 3k | $49,015.00 | $145M | By IRA | 11/01/2021 |
| 11/01/2021 | VERACYTE, INC. | VCYT | Sale | Common Stock | 1.2k | $49.48 | $61.4k | By IRA | 11/01/2021 |
| 09/22/2021 | NEKTAR THERAPEUTICS | NKTR | Grant | | 10.2k | $0.00 | $0 | | 09/22/2021 |
| 09/22/2021 | NEKTAR THERAPEUTICS | NKTR | Grant | Stock Option | 20.4k | $17.78 | $362.7k | | 09/22/2021 |
| 08/02/2021 | VERACYTE, INC. | VCYT | Sale | Common Stock | 1.6k | $44.57 | $69.3k | By IRA | 08/02/2021 |
| 08/02/2021 | VERACYTE, INC. | VCYT | Sale | Common Stock | 2.8k | $43.54 | $123.9k | By IRA | 08/02/2021 |
| 06/08/2021 | VERACYTE, INC. | VCYT | Grant | Common Stock | 8.7k | $0.00 | $0 | | 06/08/2021 |
| 05/14/2021 | Personalis, Inc. | PSNL | Grant | Common Stock | 2.7k | $0.00 | $0 | | 05/14/2021 |
| 05/14/2021 | Personalis, Inc. | PSNL | Grant | Stock Option (right to buy) | 4.2k | $19.74 | $83.5k | | 05/14/2021 |
| 05/03/2021 | VERACYTE, INC. | VCYT | Sale | Common Stock | 3.5k | $48.01 | $169.3k | By IRA | 05/03/2021 |
| 05/03/2021 | VERACYTE, INC. | VCYT | Sale | Common Stock | 650 | $49.00 | $31.8k | By IRA | 05/03/2021 |
| 05/03/2021 | VERACYTE, INC. | VCYT | Sale | Common Stock | 250 | $50.03 | $12.5k | By IRA | 05/03/2021 |
| 02/25/2021 | VERACYTE, INC. | VCYT | Sale | Common Stock | 2.4k | $60.03 | $146.7k | | 02/25/2021 |
| 02/25/2021 | VERACYTE, INC. | VCYT | Sale | Common Stock | 3.6k | $61.09 | $220.3k | | 02/25/2021 |
| 02/25/2021 | VERACYTE, INC. | VCYT | Sale | Common Stock | 200 | $61.77 | $12.4k | | 02/25/2021 |
| 02/25/2021 | VERACYTE, INC. | VCYT | Exercise | Stock Option (right to buy) | 6.2k | $4.00 | $25k | | 02/25/2021 |
| 02/25/2021 | VERACYTE, INC. | VCYT | Sale | Common Stock | 2.4k | $60.03 | $146.7k | | 02/25/2021 |
| 02/25/2021 | VERACYTE, INC. | VCYT | Sale | Common Stock | 3.6k | $61.09 | $220.3k | | 02/25/2021 |
| 02/25/2021 | VERACYTE, INC. | VCYT | Sale | Common Stock | 200 | $61.77 | $12.4k | | 02/25/2021 |
|
|